Lloyd A. Rowland, VP Legal & General Counsel at AMYLIN PHARMACEUTICALS INC (AMLN), sold 2,000 shares at $37.39 ($75K) on 2007-03-01, disclosed to the SEC on 2007-03-02.
Scheduled sale ($75k) by VP Legal & General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.39 | 25 | $935 | 1.3% |
| 2 | $37.39 | 1,975 | $74K | 98.8% |
| Total | $37.39 avg | 2,000 | $75K | 100% |
| Filing → |
| CTMX | SELL | 2024-03-21 | $11K | — | Filing → |
| CTMX | SELL | 2023-12-22 | $6K | — | Filing → |
| CTMX | SELL | 2023-09-22 | $7K | — | Filing → |